EUVIMEDEUVIMED entdecken
Crossref

Memory B Cells Provide Long‐Term Protection to Vaccinated Kidney Transplant Recipients Against SARS‐CoV‐2 Variants

Maxime Espi iD, Xavier Charmetant, Ilies Benotmane, Katia Lefsihane, Véronique Barateau, Floriane Gallais, Hafsa Boulenouar, Anne Ovize, Alexia Barbry, Christine Bouz, Emmanuel Morelon, Thierry Defrance und 3 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Maxime Espi und 14 weiteren Autor:innen. Beteiligte Einrichtung: CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplant recipients (KTRs) are highly vulnerable to COVID‐19. An intensified scheme of vaccination offers short‐term protection to the 50%–75% of KTRs able to develop a germinal center reaction, required for the generation of neutralizing titers of antibodies (NAbs). However, the duration of this vaccinal protection is unknown. In‐depth longitudinal analysis of the immune response to vaccination of 33 KTRs demonstrates that the low peak of IgGs, the progressive decline in antibody titers, and the emergence of a variant of concerns (VOC) of SARS‐CoV2, synergize to let 2/3 of responders to vaccine without NAbs after only a few months. Yet, a retrospective study of an independent cohort of 274 KTRs, revealed that the risk of severe COVID‐19 in the latter was low, similar to that of patients with serum neutralizing capacity against VOC. Our work links this late vaccine protection with the presence of memory B cells, which are generated during the initial vaccine‐induced germinal center reaction, have a wide repertoire directed against conserved spike epitopes, and rapidly differentiate into IgG‐producing plasma cells upon antigenic rechallenge. We conclude that in contrast with a serological layer that goes fading rapidly, the cellular layer of humoral memory provides an efficient long‐term protection against VOC to KTRs. This illustration of the complementary roles of the two layers of the humoral memory has implications in immunopathology beyond the COVID‐19 in KTRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19SARS-CoV-2Antibodies, ViralAntibodies, NeutralizingTransplant RecipientsCOVID-19 VaccinesMemory B CellsHumansMiddle AgedMaleFemaleRetrospective StudiesAgedAdultImmunoglobulin GVaccinationLongitudinal Studies

Stichwörter der Autor:innen

coronavirusdisease controlimmune responsesvaccines/vaccine strainsvirus classification

Substanzen

Antibodies, ViralAntibodies, NeutralizingCOVID-19 VaccinesImmunoglobulin G

Autor:innen und Institutionen

  • CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.
  • Department of Transplantation, Hospices Civils de Lyon, Edouard Herriot Hospital, Nephrology and Clinical Immunology, Lyon, France.
  • Claude Bernard University, Villeurbanne, France.
  • Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Inserm UMR S1109, LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
  • Department of Virology, Strasbourg University Hospital, Strasbourg, France.

ORCID-Profile: Maxime Espi

Zitieren

APA

Espi, M., Charmetant, X., Benotmane, I., Lefsihane, K., Barateau, V., Gallais, F., Boulenouar, H., Ovize, A., Barbry, A., Bouz, C., Morelon, E., Defrance, T., Fafi-Kremer, S., Caillard, S., & Thaunat, O. (2024). Memory B Cells Provide Long‐Term Protection to Vaccinated Kidney Transplant Recipients Against SARS‐CoV‐2 Variants. Journal of Medical Virology. https://doi.org/10.1002/jmv.70037

Vancouver

Espi M, Charmetant X, Benotmane I, Lefsihane K, Barateau V, Gallais F, et al. Memory B Cells Provide Long‐Term Protection to Vaccinated Kidney Transplant Recipients Against SARS‐CoV‐2 Variants. Journal of Medical Virology. 2024. doi:10.1002/jmv.70037

BibTeX
@article{Espi2024,
  author = {Espi, Maxime and Charmetant, Xavier and Benotmane, Ilies and Lefsihane, Katia and Barateau, Véronique and Gallais, Floriane and Boulenouar, Hafsa and Ovize, Anne and Barbry, Alexia and Bouz, Christine and Morelon, Emmanuel and Defrance, Thierry and Fafi-Kremer, Samira and Caillard, Sophie and Thaunat, Olivier},
  title = {Memory B Cells Provide Long‐Term Protection to Vaccinated Kidney Transplant Recipients Against SARS‐CoV‐2 Variants},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70037}
}
Kostenlos starten →